To report secondary efficacy endpoints of Radiation Therapy Oncology Group protocol 0247 , primary endpoint analysis of which demonstrated that preoperative radiation therapy ( RT ) with capecitabine plus oxaliplatin achieved a pathologic complete remission prespecified threshold ( 21 % ) to merit further study , whereas RT with capecitabine plus irinotecan did not ( 10 % ) .